Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Diffuse secondary atrophy of choroid, left eye (ICD Code: H31.122)
Summary
Diffuse secondary atrophy of the choroid, left eye, is a condition characterized by widespread degeneration and thinning of the choroidal tissue in the left eye, resulting from an underlying cause. This process can lead to structural changes in the choroid, potentially impacting retinal health and visual function depending on the extent and location of the atrophy.
Causes
Diffuse secondary atrophy of the choroid typically results from systemic diseases, chronic inflammation, or vascular insufficiency affecting ocular blood flow. Common underlying causes include hypertension, atherosclerosis, autoimmune disorders, or long-term exposure to certain environmental factors. In some cases, it may be associated with infections or neoplastic processes.
Risk Factors
- Advanced age
- Systemic vascular diseases (e.g., hypertension, atherosclerosis)
- Chronic ocular inflammation or infection
- Autoimmune disorders
- Prolonged exposure to ultraviolet light
- Genetic predispositions
Symptoms
- Gradual loss of peripheral or central vision in the left eye
- Blurred or distorted vision in the left eye
- Difficulty adapting to low light conditions in the left eye
- Visual field defects in the left eye
- Reduced visual acuity in advanced cases
Diagnosis
Diagnosis involves a comprehensive eye examination, including dilated fundus evaluation to assess choroidal structure. Imaging techniques such as optical coherence tomography (OCT) or fluorescein angiography may be used to evaluate the extent of atrophy and rule out other conditions. Clinical correlation with underlying systemic or ocular diseases is essential for accurate diagnosis.
Treatment Options
Treatment focuses on addressing the underlying cause to slow progression. Management may include controlling systemic conditions (e.g., hypertension, autoimmune disorders), anti-inflammatory therapies, or vascular support measures. Regular monitoring of visual function and ocular health is recommended to track changes.
Prognosis and Follow-Up
Prognosis depends on the underlying cause and severity of atrophy. Early intervention may help preserve vision, but advanced cases may lead to irreversible visual impairment. Follow-up typically involves periodic eye examinations to monitor progression and adjust treatment as needed.
Complications
Potential complications include progressive vision loss, retinal damage, or secondary ocular conditions due to impaired choroidal function. In severe cases, irreversible visual impairment may occur.
Lifestyle & Prevention
- Manage systemic conditions (e.g., blood pressure, diabetes) to reduce vascular risk.
- Protect eyes from excessive ultraviolet light with sunglasses.
- Avoid smoking, which can worsen vascular health.
- Maintain regular eye exams, especially if risk factors are present.
When to Seek Professional Help
Seek prompt medical attention if you experience sudden vision changes, persistent blurriness, or difficulty seeing in low light in the left eye. Early evaluation can help identify underlying causes and prevent further damage.
Tips for Medical Coders
Document the laterality (left eye) clearly in the medical record to support accurate coding. Ensure the underlying cause, if known, is documented to differentiate secondary atrophy from primary conditions. Use H31.122 for diffuse secondary atrophy of the choroid specifically affecting the left eye.
H31.122 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.